3/26
09:33 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
High
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
3/26
09:33 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
High
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
3/26
09:27 am
atxs
Rating for ATXS
High
Report
Rating for ATXS
3/26
09:27 am
atxs
Rating for ATXS
High
Report
Rating for ATXS
3/26
07:11 am
atxs
Rating for ATXS
Medium
Report
Rating for ATXS
3/26
07:11 am
atxs
Rating for ATXS
Medium
Report
Rating for ATXS
3/25
01:01 pm
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
3/18
03:10 pm
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
3/5
09:11 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
3/5
09:11 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
3/5
08:32 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS
3/5
08:32 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS
3/5
08:14 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
1/30
11:20 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
1/30
11:20 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
1/30
11:01 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS
1/30
11:01 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS